| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd7681692989a5aabe7b2a04b71628bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2385068486a983fa9bda85f073f6e6ab |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_299e20c53e6ceee40dc29dc6f54722d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3290942303f473a2340faf6da7146c6 |
| publicationDate |
2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008274121-A1 |
| titleOfInvention |
Inhibition of Angiogenesis by Mithramycin |
| abstract |
We disclose a method of inhibiting angiogenesis in a mammal by administering by a subcutaneous or intraperitoneal route to a tissue in the mammal where angiogenesis is occurring a composition comprising mithramycin and a pharmaceutically-acceptable carrier. We have found a subcutaneous or intraperitoneal dose from about 10 μg mithramycin per kg body weight per day to about 500 μg mithramycin per kg body weight per day can be effective for inhibition of angiogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359363-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012027524-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010064736-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2709450-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013150317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2709450-A4 |
| priorityDate |
2007-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |